<DOC>
	<DOC>NCT01398839</DOC>
	<brief_summary>The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL) when used to treat ectasia.</brief_summary>
	<brief_title>Safety Study of the VEGA UV-A System to Treat Ectasia</brief_title>
	<detailed_description />
	<mesh_term>Dilatation, Pathologic</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>18 Years of age or older Diagnosis of Ectasia Presence of central or inferior steepening Topography consistent with ectasia BSCVA 20/20 or worse If contact lens wearer; removal of contact lenses for required period of time Signed informed consent Willingness and ability to comply with schedule for followup visits Previous ocular condition that may predispose the eye for future complications or prevent the possibility of improved vision History of chemical injury or delayed epithelial healing A known sensitivity to study medications Nystagmus or any other condition that would prevent a steady gaze during the treatment or other diagnostic tests A condition that would interfere with or prolong epithelial healing Presence or history of any other condition or finding that makes the patient unsuitable for treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>